Latest Processing News

The Takeovers Panel has declined to examine a challenge to Zenith Minerals’ handling of Aurenne’s proposed $5 million funding, removing one regulatory obstacle to Forrestania Resources’ recommended takeover. The Panel said there was no reasonable prospect of declaring unacceptable circumstances, but detailed reasons are still to come.

Sunrise Energy Metals has completed key Syerston engineering work and received a conditional commitment for up to US$400 million in long-term debt from the U.S. Office of Strategic Capital. The project’s revised scope now carries an estimated A$450 million to A$475 million capital cost, while the proposed Nasdaq redomiciliation remains subject to multiple approvals.

European Resources has lifted bench-scale magnet rare earth extraction at its Korsnäs project to 92% and is moving towards a mixed rare earth carbonate sample for potential customer assessment. The progress comes alongside a new eastern exploration anomaly and a reported cash runway of about two quarters.

Bannerman Energy and CNNC Overseas have approved the Final Investment Decision for the Etango uranium project in Namibia, clearing the way for full-scale construction and targeting first yellowcake in 2028. The project is forecast to produce about 3.5 million pounds of U3O8 annually, with construction funding described as covered by existing cash balances.

Patagonia Lithium’s application for a 1,000-tonne lithium carbonate demonstration plant has passed the gazettal stage in Argentina, but final environmental approval remains outstanding. The company has also pushed back its Mineral Resource Estimate update by five weeks while it resolves conflicting porosity data.

PeopleIN improved underlying earnings and reduced leverage in FY26 despite a statutory loss, as Queensland’s infrastructure demand drove a sharp recovery in its core workforce division. The company is now betting that a leaner portfolio, Infrawork’s trans-Tasman labour channel and Brisbane 2032-related work can sustain the upturn.

Equus Energy has secured a binding conditional 10-year gas sales agreement with Alcoa covering about 50 TJ a day, while receiving US$1.5 million to fund the next stage of project partnering. The milestone strengthens the commercial case for the Equus Gas Project, but the development remains pre-FID and requires substantial capital, partners and approvals.

Paradigm’s administrators have asked the Supreme Court of Western Australia for up to three more months to assess sale and recapitalisation proposals. Without the extension, they say they would have no alternative but to recommend winding up the biotech.

Whitehaven Coal has opened FY27 with a 22% year-on-year jump in managed ROM production, while terminal disruptions pushed equity sales lower and lifted inventories. Costs remained at the low end of guidance, prices strengthened and full-year targets were unchanged.

Acusensus has secured a five-year ACT Government traffic enforcement contract valued at approximately $63 million, with extension options that could lift the total to $210 million. The deal broadens its role from specialist detection to a territory-wide enforcement platform, although rollout is not expected until mid-2027.

Arovella has released two clinical batches of its off-the-shelf CAR-iNKT therapy, activated two trial sites and begun screening patients ahead of expected first dosing in October. The biotech ended September with A$11.6 million in cash, rising to about A$15.63 million pro forma after an R&D rebate.

BluGlass has expanded its customer-funded GaN laser programs with a A$1.4 million Uviquity contract and a new A$286,000 photonics collaboration. But its A$8 million facility is fully drawn, carries 16.5% interest and leaves reported funding coverage at 2.8 quarters.